Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV

By: via Benzinga
Gilead Sciences, Inc. (NASDAQ: GILD) disclosed the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.